Emory University: Diabetes Mellitus, Type 2 trials

The registry lists 29 Diabetes Mellitus, Type 2 studies with Emory University as lead sponsor. 3 are open to participants now and 21 have results posted.

Phase 3 2Phase 4 13No phase 14(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Diabetes Multimorbidity Typology, Trajectory, and Feasibility of an Audio Diary Mobile Application to Support Self-managementRecruitingNCT07474376Not applicable
• Investigating the Impact of GLP-1 RA Therapy on Osteosarcopenia in Older Female Adults With DiabetesRecruitingNCT07428746Phase 3
• Modeling Ketosis-Prone Diabetes Remission Via Diverse Mechanisms of GlucotoxicityRecruitingNCT06699810Phase 4
• Embedded Primary Care MultiDisciplinary Diabetes ClinicCompletedNCT06015685Not applicableResults posted
• SomaSignal Tests on Medical Management and Change in Risk in Patients With DiabetesCompletedNCT05256706Not applicableResults posted
• Well-child Visit Video ProjectCompletedNCT05011292Not applicableResults posted
• Dexcom Continuous Glucose Monitoring in Long-term CareCompletedNCT04818242Not applicableResults posted
• Cryovagotomy Diabetes TrialCompletedNCT04276051Not applicableResults posted
• Mindfulness IN-home for Diabetes and Sleep HealthCompletedNCT04160078Not applicableResults posted
• A Sleep Intervention (SLEEP-Extend) for Young Adults At-Risk for Type 2 DiabetesCompletedNCT03616171Not applicableResults posted
• Cognitive Behavioral Therapy for African Americans With Uncontrolled Type-2 DiabetesTerminatedNCT03562767Not applicableResults posted
• Insulin Degludec and Glargine U100 for Management of Hospitalized and Discharged Patients With Type 2 DiabetesCompletedNCT03336528Phase 4Results posted
• A Randomized Study to Evaluate the Efficacy of Insulclock® in Patients With Uncontrolled Type 2 DiabetesCompletedNCT03224234Not applicableResults posted
• Glargine U300 Hospital TrialCompletedNCT03013985Phase 4Results posted
• Exenatide Inpatient Trial: A Randomized Controlled Pilot Trial on the Safety and Efficacy of Exenatide (Byetta®) Therapy for the Inpatient Management of Patients With Type 2 DiabetesCompletedNCT02455076Phase 4Results posted
• Benefits of Insulin Supplementation for Correction of Hyperglycemia in Patients With Type 2 DiabetesCompletedNCT02408120Phase 4Results posted
• Linagliptin Inpatient TrialCompletedNCT02004366Phase 4Results posted
• Liraglutide Hospital Discharge TrialCompletedNCT01919489Phase 4Results posted
• Sitagliptin Therapy in Hospitalized Patients With Type 2 DiabetesCompletedNCT01845831Phase 4Results posted
• Dipeptidyl Peptidase-4 Inhibitor (Sitagliptin) Therapy in the Inpatients With Type 2 DiabetesCompletedNCT01378117Phase 4Results posted
• Mechanism Underlying Beta-cell Failure in Obese African Americans With History of Hyperglycemic CrisesCompletedNCT00753142Not applicableResults posted
• Free Fatty Acid-Induced Hypertension in Obese Subjects With Type 2 DiabetesCompletedNCT00738023Phase 4Results posted
• Basal Bolus Insulin Versus SSRI in Type 2 Diabetes Undergoing General SurgeryCompletedNCT00596687Phase 4Results posted
• Insulin Detemir Versus NPH Insulin In Hospitalized Patients With DiabetesCompletedNCT00590226Phase 4Results posted
• Automated Insulin Delivery for Inpatients With DysglycemiaCompletedNCT06418880Phase 3
• Percutaneous CT-guided Cryoablation of the Splanchnic NervesWithdrawnNCT04569721Not applicable
• Redox Imbalance and the Development of Cystic Fibrosis DiabetesCompletedNCT02202876Not applicable
• Safety and Efficacy Study of Correcting Hyperglycemia in Patients With Diabetes Having Out-patient SurgeryWithdrawnNCT01971047Phase 4
• A Randomized Trial of Diabetes Prevention Through Lifestyle Change in IndiaCompletedNCT01283308Not applicable